<DOC>
	<DOC>NCT01408069</DOC>
	<brief_summary>The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different associations of drugs in the treatment of patients diagnosed with tensional-type headache in accordance with International Headache Society guidelines.</brief_summary>
	<brief_title>Non-Inferiority Comparison of Migrane® Versus Parcel ® For Treatment of Tensional Cephaleia</brief_title>
	<detailed_description>- Open-label, non-inferiority, prospective, parallel group, intent to treat trial. - Experiment duration: 56 days. - 04 visits (days -7, 0, 28 and 56). - Efficacy will be evaluated for 10 episodes of tension-type headache. - Adverse events evaluation.</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Ergotamine</mesh_term>
	<criteria>1. Patients must be able to understand the study procedures agree to participate and give written consent. 2. Tensionaltype headache patients according to the International Headache Society criteria. 3. Corporal body indices &lt; 40. 1. Pregnancy or risk of pregnancy. 2. Lactation 3. Use of acetylsalicylic acid or corticosteroids or immunosuppressive therapy. 4. Use of immunosuppressive drugs. 5. Alterations of laboratory selective tests. 6. Drugs or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>headache</keyword>
	<keyword>migraine</keyword>
</DOC>